Case Study on Moderna Published by Harvard Business School:
— Brook Jackson 💜 (@IamBrookJackson) January 22, 2023
"The level of reckless disregard for product safety, rational drug design, rigorous testing and quality control in biologics manufacturing is astounding." – Sasha Latypova https://t.co/No4l9lwTyt
Never ends….
https://www.facebook.com/photo/?fbid=1533717978789880&set=a.613223177506036

